# Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

> **NCT00334958** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 356 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Placebo
- **DRUG:** Rufinamide

## Key facts

- **NCT ID:** NCT00334958
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-13
- **Primary completion:** 2009-05-20
- **Final completion:** 2009-05-20
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334958, "Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00334958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*